Related Experiment Video
Updated: Jun 25, 2026

Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease
1Department of Biochemistry & Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Abstract:
The MEP1A gene, located on human chromosome 6p (mouse chromosome 17) in a susceptibility region for inflammatory bowel disease (IBD), encodes the alpha-subunit of metalloproteinase meprin A, which is expressed in the intestinal epithelium. This study shows a genetic association of MEP1A with IBD in a cohort of ulcerative colitis (UC) patients. There were four single-nucleotide polymorphisms in the coding region (P=0.0012-0.04), and one in the 3'-untranslated region (P=2 x 10(-7)) that displayed associations with UC. Moreover, meprin-alpha mRNA was decreased in inflamed mucosa of IBD patients. Meprin-alpha knockout mice exhibited a more severe intestinal injury and inflammation than their wild-type counterparts following oral administration of dextran sulfate sodium. Collectively, the data implicate MEP1A as a UC susceptibility gene and indicate that decreased meprin-alpha expression is associated with intestinal inflammation in IBD patients and in a mouse experimental model of IBD.
Insights
The MEP1A gene is linked to ulcerative colitis (UC), a type of inflammatory bowel disease (IBD). Reduced meprin-alpha expression in the gut is associated with IBD severity in patients and mouse models.
Area of Science:
- Genetics
- Gastroenterology
- Immunology
Background:
- The MEP1A gene, encoding meprin-alpha, is located in a region associated with inflammatory bowel disease (IBD).
- Meprin-alpha is expressed in the intestinal epithelium, suggesting a role in gut health.
Purpose of the Study:
- To investigate the association of the MEP1A gene with ulcerative colitis (UC), a major form of IBD.
- To examine the role of meprin-alpha expression in intestinal inflammation.
Main Methods:
- Genetic association study of single-nucleotide polymorphisms (SNPs) in the MEP1A gene in a cohort of UC patients.
- Quantitative analysis of meprin-alpha mRNA levels in inflamed intestinal mucosa.
- Evaluation of intestinal injury and inflammation in meprin-alpha knockout mice using a dextran sulfate sodium (DSS) model.
Main Results:
- Significant genetic associations were found between MEP1A SNPs and UC susceptibility.
- Meprin-alpha mRNA levels were decreased in inflamed mucosa from IBD patients.
- Meprin-alpha knockout mice showed exacerbated intestinal injury and inflammation in the DSS model.
Conclusions:
- The MEP1A gene is implicated as a susceptibility gene for UC.
- Decreased meprin-alpha expression is linked to intestinal inflammation in IBD patients and experimental models.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Amebiasis
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
